| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | — |
| R&D Expense | $8.4M | +16.6% |
| SG&A Expense | $6.5M | -25.4% |
| Operating Income | -$7.8M | +51.1% |
| Interest Expense | $0 | -100.0% |
| Net Income | -$2.2M | +86.1% |
| EPS (Basic) | -$0.82 | +89.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | -22.9% |
| Current Assets | $10.0M | -56.0% |
| Total Assets | $10.0M | -55.9% |
| Total Liabilities | $2.6M | +7.4% |
| Stockholders' Equity | $7.4M | -63.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +50.2% |
| Financing Cash Flow | $11.1M | — |